Search research articles
Contact Us
Filters
Showing results (1-10 of 12) with videos related to
Page
of 2
Sort By:
Biotechnology Healthcare
|
January 16, 2013
Taking control of compliance
Scott Kober
Biotechnology Healthcare
|
February 8, 2013
Looking at Biotech's Crystal Ball: The issues we'll be focused on in 2005
Scott Kober
Managed Care (Langhorne, Pa.)
|
May 12, 2007
Managed care seeks more from clinical laboratories. Contracting advantage has sometimes been with the nationwide labs, but health plans are getting serious about price, service, and patient data
Scott Kober
Biotechnology Healthcare
|
February 21, 2013
CMS' CAP Program: Worthy of Applause - Or Full of Flaws?
Scott Kober
Biotechnology Healthcare
|
April 6, 2012
Managing Second-line Biologics: Worth the Effort?
Scott Kober
Biotechnology Healthcare
|
April 6, 2012
Personalized Medicine: Tomorrow's Promise or Today's Reality?
Scott Kober
Biotechnology Healthcare
|
April 6, 2012
When it comes to SP, employer size matters
Scott Kober
Biotechnology Healthcare
|
April 6, 2012
Cutting back expenses through carve-outs
Scott Kober
Biotechnology Healthcare
|
February 21, 2013
Q&A: Steven E. McKenzie, MD, PhD: At the Intersection of Academic Research and Biomedicine
Scott Kober
Biotechnology Healthcare
|
February 9, 2013
Expect p&t committees to demand more data
Scott Kober
Page
of 2
Search research articles
Search
Showing results (1-10 of 12) with videos related to
Sort By:
Page
of 2
Biotechnology Healthcare
|
January 16, 2013
Taking control of compliance
Scott Kober
Biotechnology Healthcare
|
February 8, 2013
Looking at Biotech's Crystal Ball: The issues we'll be focused on in 2005
Scott Kober
Managed Care (Langhorne, Pa.)
|
May 12, 2007
Managed care seeks more from clinical laboratories. Contracting advantage has sometimes been with the nationwide labs, but health plans are getting serious about price, service, and patient data
Scott Kober
Biotechnology Healthcare
|
February 21, 2013
CMS' CAP Program: Worthy of Applause - Or Full of Flaws?
Scott Kober
Biotechnology Healthcare
|
April 6, 2012
Managing Second-line Biologics: Worth the Effort?
Scott Kober
Biotechnology Healthcare
|
April 6, 2012
Personalized Medicine: Tomorrow's Promise or Today's Reality?
Scott Kober
Biotechnology Healthcare
|
April 6, 2012
When it comes to SP, employer size matters
Scott Kober
Biotechnology Healthcare
|
April 6, 2012
Cutting back expenses through carve-outs
Scott Kober
Biotechnology Healthcare
|
February 21, 2013
Q&A: Steven E. McKenzie, MD, PhD: At the Intersection of Academic Research and Biomedicine
Scott Kober
Biotechnology Healthcare
|
February 9, 2013
Expect p&t committees to demand more data
Scott Kober
Page
of 2